Waters Corp, Thermo Fisher, & Analytical Lab Instruments: A Customer's Perspective
R&D and Innovation Director at Quality Assistance
inpractise.com/articles/waters-corp-thermo-fisher-shimadzu-agilent
R&D and Innovation Director at Quality Assistance
Interview Transcript
This is a snippet of the transcript, sign up to read more.
As I said, I have access to the numbers, but it's interesting to hear from someone who actually works with their products. When you decide to buy a liquid chromatography instrument, how do you make that decision?
As a service company, it's critical for us to offer services for many years without needing to frequently change our equipment. Hence, reliability and support are vital to us. More broadly, application and technical support are very important. In Belgium, at least, Waters leads in this aspect. We know that when we purchase equipment, we'll receive support for the installation, as well as ongoing technical and application support. The service contract they offer is also significant. Knowing that if an issue arises, someone can be onsite within 24 to 48 hours is critical for us.
This is a snippet of the transcript, sign up to read more.
Related Content
Waters Corporation: Product Innovation, Support Services & Switching Cost
Former Senior Scientist at Waters Corporation
Waters Corp: Analytical Lab Instruments Market Dynamics
Former VP of Product Instrument Development at Waters Corporation
GYM, Danaher Cytiva Consumables, Lifco, Waters Corp, Terravest, Domino's, GoEasy, PRKS, EVO
Danaher: M&A Runway, Target Evaluation Process & Valuations
Former VP Life Science Group at Danaher
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.